Elsevier

Biochemical Pharmacology

Volume 47, Issue 4, 11 February 1994, Pages 711-715
Biochemical Pharmacology

Effects of anandamide on cannabinoid receptors in rat brain membranes

https://doi.org/10.1016/0006-2952(94)90134-1Get rights and content

Abstract

Anandamide (arachidonylethanolamide) is a compound recently isolated from porcine brain as a putative endogenous ligand at cannabinoid receptors. The present studies examined the effects of anandamide on cannabinoid receptor binding sites and adenylyl cyclase in rat brain membranes. Receptor binding experiments, conducted at 25° for 90 min, apparently resulted in significant degradation of anandamide, since anandamide (10 μM) had little effect on [3H]WIN 55212-2 binding in cerebellar membranes. Addition of the general serine protease inhibitor phenylmethylsulfonyl fluoride (PMSF) protected against this degradation, resulting in an ic50 value of 90 nM for anandamide versus [4H]WIN 55212-2 binding. Anandamide inhibited adenylyl cyclase in cerebellar membranes in a GTP-dependent manner, exhibiting a maximal inhibition level slightly less than that of WIN 55212-2 and CP-55,940, with an ic50 value of 1.9 μM. The effect of anandamide on adenylyl cyclase was region-specific, with maximal inhibition occurring in cerebellum and striatum. These results suggest that anandamide acts at G-protein-coupled cannabinoid receptors in brain with properties similar to those of exogenous cannabinoids.

References (25)

  • K Mackie et al.

    Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells

  • MP Caulfield et al.

    Cannabinoid receptor agonists inhibit C current in NG108-15 neuroblastoma cells via a Pertussis toxin-sensitive mechanism

    Br J Pharmacol

    (1992)
  • Cited by (166)

    • The endocannabinoid system in the visual process

      2023, Journal of Photochemistry and Photobiology
    • Cannabinoid Receptors and Their Signaling Mechanisms

      2017, The Endocannabinoid System: Genetics, Biochemistry, Brain Disorders, and Therapy
    • Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: A comprehensive review from an analytical and biological perspective

      2011, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
      Citation Excerpt :

      In clinical studies, containers with EDTA-anticoagulated blood should be immediately put in an ice bath followed by centrifugation in the cold, be portioned (e.g., in 1-mL aliquots), frozen as soon as possible at − 80 °C and stored at this temperature until analysis. Inhibition of unspecific amidases, esterases and proteases through externally added inhibitors such as phenylmethylsulfonyl fluoride (PMSF) has been successfully tested as an approach to prevent EC hydrolysis following blood sampling [115]. However, whole blood incubation with PMSF at 37 °C for 24 h prior to plasma generation by centrifugation produces significantly higher plasma EC concentrations [116].

    • The endogenous cannabinoid anandamide shares discriminative stimulus effects with △<sup>9</sup>-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice

      2011, European Journal of Pharmacology
      Citation Excerpt :

      Further, while AEA evoked a transient cannabimimetic profile as assessed through the tetrad (hypolocomotion, hypothermia, antinociception, catalepsy; Smith et al., 1994), AEA failed to influence other behaviors typically altered by cannabinoids, including anxiety-like behavior, memory and food intake (Crawley et al., 1993). Further, significant AEA binding in rat brain homogenate was attained only in the presence of the non-specific serine protease inhibitor phenylmethylsulfonyl fluoride (PMSF; Childers et al., 1994). These results, along with others, strongly suggested that AEA was rapidly metabolized, hence the general lack of cannabinoid activity in vivo.

    • Chapter 4 Anandamide Receptor Signal Transduction

      2009, Vitamins and Hormones
      Citation Excerpt :

      For many years, reports of this nature were largely brushed aside as being a result of rapid metabolism. These concerns, although valid, were countered by the use of the metabolically stable derivative, methanandamide, and inhibitors of anandamide degradation coupled with more stringent controls in many publications (Abadji et al., 1994; Breivogel et al., 1998; Childers et al., 1994; Deutsch, 2005; Pinto et al., 1994). In GTPγS assays performed with both rat brain membranes and membranes from CHO cells transfected with human CB1 receptor anandamide acts as a partial agonist (Breivogel et al., 1998; Gonsiorek et al., 2000).

    • Development of novel tail-modified anandamide analogs

      2008, Bioorganic and Medicinal Chemistry Letters
    View all citing articles on Scopus
    View full text